These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 9815768)
1. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo. Lindner DJ; Borden EC; Kalvakolanu DV Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768 [TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro. Lindner DJ; Borden EC J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106 [TBL] [Abstract][Full Text] [Related]
3. Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin. Yokota S; Hara H; Luo Y; Seon BK Cancer Res; 1990 Jan; 50(1):32-7. PubMed ID: 2293557 [TBL] [Abstract][Full Text] [Related]
4. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells. Marth C; Daxenbichler G; Dapunt O J Natl Cancer Inst; 1986 Dec; 77(6):1197-202. PubMed ID: 3099046 [TBL] [Abstract][Full Text] [Related]
5. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines. Liu L; Gudas LJ J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088 [TBL] [Abstract][Full Text] [Related]
7. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. Agarwal C; Hembree JR; Rorke EA; Eckert RL Cancer Res; 1994 Apr; 54(8):2108-12. PubMed ID: 8174114 [TBL] [Abstract][Full Text] [Related]
8. Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin. Bauer JA; Morrison BH; Grane RW; Jacobs BS; Dabney S; Gamero AM; Carnevale KA; Smith DJ; Drazba J; Seetharam B; Lindner DJ J Natl Cancer Inst; 2002 Jul; 94(13):1010-9. PubMed ID: 12096086 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Sidky YA; Borden EC Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862 [TBL] [Abstract][Full Text] [Related]
10. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines. Coradini D; Biffi A; Pirronello E; Di Fronzo G Anticancer Res; 1994; 14(5A):1779-84. PubMed ID: 7531412 [TBL] [Abstract][Full Text] [Related]
11. Effects of all-trans retinoic acid and interferon-gamma on expression of RAR beta gene in Tca8113 cells. Chen WT; He RG; Liu XK; Zhou XJ Chin J Dent Res; 1999 Dec; 2(3-4):25-30. PubMed ID: 10863413 [TBL] [Abstract][Full Text] [Related]
12. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells. Abemayor E Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787 [TBL] [Abstract][Full Text] [Related]
13. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Chawla-Sarkar M; Leaman DW; Borden EC Clin Cancer Res; 2001 Jun; 7(6):1821-31. PubMed ID: 11410525 [TBL] [Abstract][Full Text] [Related]
14. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction. Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617 [TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821 [TBL] [Abstract][Full Text] [Related]
16. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Lingen MW; Polverini PJ; Bouck NP Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093 [TBL] [Abstract][Full Text] [Related]
17. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons. Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097 [TBL] [Abstract][Full Text] [Related]
18. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis. Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427 [TBL] [Abstract][Full Text] [Related]
19. Interaction of retinoic acid and interferon-alpha in breast cancer cell lines. Widschwendter M; Daxenbichler G; Bachmair F; Müller E; Zeimet AG; Windbichler G; Uhl-Steidl M; Lang T; Marth C Anticancer Res; 1996; 16(1):369-74. PubMed ID: 8615638 [TBL] [Abstract][Full Text] [Related]
20. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis. Lindner DJ; Borden EC Int J Cancer; 1997 May; 71(3):456-61. PubMed ID: 9139884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]